Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats

British Journal of Cancer

Volumn 103, Issue 12, 2010, Pages 1840-1845

  You, J F ^a,b,c   Buhard, O ^a,b   Ligtenberg, M J L ^d   Kets, C M ^d   Niessen, R C ^e   Hofstra, R M W ^e   Wagner, A ^f   Dinjens, W N M ^g   Colas, C ^a,b,h   Lascols, O ^b,i   Collura, A ^a,b   Flejou, J F ^a,b,i   Duval, A ^a,b   Hamelin, R ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^h CENTRE DE RECHERCHE SAINT ANTOINE   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Lynch syndrome; microsatellite instability; MSH6

Indexed keywords

PROTEIN MSH6;

ARTICLE; COLON TUMOR; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; ENDOMETRIUM TUMOR; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MISMATCH REPAIR; NUCLEOTIDE REPEAT; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMALL INTESTINE RESECTION; URINARY TRACT TUMOR;

DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; HUMANS; MICROSATELLITE INSTABILITY; NEOPLASMS; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 78650026298     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605988     Document Type: Article

References (24)

1. Berends MJW, Wu Y, Sijmons RH, Mensink RGJ, van der Sluis T, Hordijk-Hos JM, de Vries EGE, Hollema H, Karrenfeld A, Buys CHCM, van der Zee AGJ, Hofstra RMW, Kleibeuker JH (2002) Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant. Am J Hum Genet 70: 26-37
2. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodrigues-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257
3. Brennetot C, Buhard O, Jourdan F, Flejou JF, Duval A, Hamelin R (2005) Mononucleotide repeats BAT-26 and BAT-25 accurately detect MSI-H tumors and predict tumor content: Implications for population screening. Int J Cancer 113: 445-450
4. Buhard O, Cattaneo F, Wong YF, Yim SF, Friedman E, Flejou JF, Duval A, Hamelin R (2006) Multi-population analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol 24: 241-251
5. Buhard O, Suraweera N, Lectard A, Duval A, Hamelin R (2004) Quasimonomorphic mononucleotide repeats for high level microsatellite instability analysis. Dis Markers 20: 251-257
6. Drummond JT, Li GM, Longley MJ, Modrich P (1995) Isolation of an MSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 268: 1909-1912
7. Goel A, Nagasaka T, Hamelin R, Boland CR (2010) An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers. PLoS ONE 5: E9393
8. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57: 808-811
9. Kets CM, van Krieken JHJM, Hebeda KM, Weznberg SJ, Goosens M, Brunner HG, Ligtenberg MJL, Hoogerbrugge N (2006) Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Br J Cancer 95: 1678-1682
10. Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Järvinen H, Sistonen P, Kim KM, Shibata D, Houslton RS, Aaltonen LA (2002) Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 62: 1166-1170 (Pubitemid 34160304)
11. Lynch HT, Lynch JF (2004) Lynch syndrome: History and current status. Dis Markers 20: 181-198
12. Mead LJ, Jenkins MA, Young J, Royce SG, Smith L, St John DJB, Macrae F, Giles GG, Hopper JL, Southey MC (2007) Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res 13: 2865-2869
13. Murphy KM, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8: 305-311
14. Peltomäki P (2005) Lynch syndrome genes. Fam Cancer 4: 227-232
15. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618
16. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S (2003) Tumor microsatellite-instability status as a predictor of benefit from Fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349: 247-257
17. Shia J (2008) Immunohistochemistry vs microstellite instability for screening colorectal cancer patients at risk for Hereditary Nonpolyposis Colorectal Cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 10: 293-300
18. Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K, Seruca R, Iacopetta B, Hamelin R (2002) Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123: 1804-1811
19. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HFA, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96: 261-268 (Pubitemid 38256271)
20. Verma L, Kane MF, Brassett C, Schmeirts J, Evans DGR, Kolodner RD, Maher ER (1999) Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer. J Med Genet 36: 678-682
21. Wong YF, Cheung TH, Kit Lo KW, Yim SF, Chan LK, Buhard O, Duval A, Chung TK, Hamelin R (2006) Detection of microsatellite instability in endometrial cancer: Advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers. Carcinogenesis 27: 951-955
22. Wu Y, Berends MJW, Mensink RBJ, Kempinga C, Sijmons RH, van der Zee AGJ, Hollema H, Kleibeuker JH, Buys CHCM, Hofstra RMW (1999) Association of hereditary nonpolyposis cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65: 1291-1298
23. Xicola RM, Llor X, Pons E, Castells A, Alenda C, Pinol V, Andreu M, Castellvi-Bel S, Paya A, Jover R, Bessa X, Giros A, Duque JM, Nicolas- Perez D, Garcia AM, Rigau J, Gassull MA (2007) Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 99: 244-252
24. Zhang L (2008) Immunohistochemistry vs microstellite instability for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn 10: 301-307